Telephone +1.909.799.8300
©2012 Optivus Proton Therapy, Inc.
Optivus Proton Therapy, Inc. • PO Box 608 • Loma Linda, CA 92354
In 1988, Loma Linda University Medical Center (LLUMC) in Southern California, under the direction of Dr. James M. Slater, undertook the unprecedented challenge of building the world’s first hospital-based Proton Beam Cancer Treatment Center. The facility would consist of three gantry rooms, one fixed-beam room and one research room.
Science – Medicine – Engineering
Proton beam therapy (PTB) is accessible, proven and reimbursable for cancer patients today in many centers around the US and abroad due to the collaborative efforts of these disciplines.
To download a pdf of our "History of Proton Therapy", please click here.
To download a pdf of our "About Optivus" brochure, please click here.
Downloads
A technical engineering team was formed and led by Jon W. Slater. He and his team were positioned at Fermi National Laboratories in Batavia, IL, to manage the development and design of the world’s smallest synchrotron accelerator for use in this new center.
Subsequently, Jon Slater and his team returned to Southern California to continue the design, development, and manage the installation of the remaining components required to commission the LLUMC proton center.
By October of 1990, only 36 short months after the initial ground-breaking, the first proton beam treatment room was fully operational and the first patient was successfully treated at LLUMC. Shortly thereafter, the original technical engineering team, led by
Jon W. Slater, was further entrusted with the ongoing technical enhancements and maintenance of the entire proton treatment center.
To meet future demands for this life saving technology within commercial markets, this technical and engineering team was transformed into a commercial business entity. On June 1, 1993, Optivus Proton Therapy, Inc. (Optivus) was founded on the principals of continuous excellence in design and development of this superior disease treatment technology.
For two decades, the Optivus team has had one mission:
To Save Lives with Proton Therapy.
